Interferon-beta therapy reduces CD4+ and CD8+ T-cell reactivity in multiple sclerosis. [electronic resource]
Producer: 20070529Description: 29-39 p. digitalISSN:- 0019-2805
- Adult
- CD4-Positive T-Lymphocytes -- immunology
- CD8-Positive T-Lymphocytes -- immunology
- Cell Proliferation
- Cells, Cultured
- Cytokines -- biosynthesis
- Disease Progression
- Flow Cytometry
- Humans
- Immunologic Memory
- Immunophenotyping
- Immunosuppressive Agents -- therapeutic use
- Interferon-beta -- therapeutic use
- Leukocyte Common Antigens -- blood
- Lymphocyte Activation -- immunology
- Middle Aged
- Multiple Sclerosis, Relapsing-Remitting -- immunology
- Myelin Proteins
- Myelin-Associated Glycoprotein -- immunology
- Myelin-Oligodendrocyte Glycoprotein
- Protein Tyrosine Phosphatase, Non-Receptor Type 1
- T-Lymphocyte Subsets -- immunology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.